Dyslipoproteinemia in Women: Special Considerations

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.

1989 • 3,169 citations

Patterns of coronary heart disease morbidity and mortality in the sexes: A 26-year follow-up of the Framingham population

1986 • 1,729 citations

Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction

1988 • 1,722 citations

Incidence of Coronary Heart Disease and Lipoprotein Cholesterol Levels

1986 • 1,464 citations

Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study.

1987 • 1,379 citations

Menopause and the Risk of Coronary Heart Disease in Women

1987 • 1,137 citations

Relation of Serum Lipoprotein Levels and Systolic Blood Pressure to Early Atherosclerosis

1986 • 1,069 citations

Increased Risk of Endometrial Carcinoma among Users of Conjugated Estrogens

1975 • 996 citations

Menopause and Coronary Heart Disease

1978 • 890 citations

A Prospective Study of Postmenopausal Estrogen Therapy and Coronary Heart Disease

1985 • 845 citations

Lipids, diabetes, and coronary heart disease: Insights from the Framingham Study

1985 • 679 citations

The triglyceride issue: A view from Framingham

1986 • 675 citations

Thromboembolic Disease and the Steroidal Content of Oral Contraceptives. A Report to the Committee on Safety of Drugs

1970 • 630 citations

Relative and Absolute Excess Risks of Coronary Heart Disease among Women Who Smoke Cigarettes

1987 • 611 citations

Oral Contraceptives and Cardiovascular Disease

1981 • 516 citations

Metabolic risk factors for coronary heart disease in women: Perspective from the Framingham Study

1987 • 483 citations

Women, work and coronary heart disease: prospective findings from the Framingham heart study.

1980 • 441 citations

Effect of gender, age, and lipid status on low density lipoprotein subfraction distribution. Results from the Framingham Offspring Study.

1987 • 395 citations

The hyperlipidemia of pregnancy in normal and complicated pregnancies

1979 • 372 citations

Effects of Different Progestogens on Lipoproteins during Postmenopausal Replacement Therapy

1981 • 353 citations

Cigarette smoking and HDL cholesterol the Framingham offspring study

1978 • 317 citations

Studies of low density lipoprotein molecular weight in human beings with coronary artery disease.

1985 • 314 citations

Cigarette Smoking and Risk of Stroke in Middle-Aged Women

1988 • 297 citations

Differences in Low Density Lipoprotein Subfractions and Apolipoproteins in Premenopausal and Postmenopausal Women*

1988 • 263 citations

A Prospective Study of Past Use of Oral Contraceptive Agents and Risk of Cardiovascular Diseases

1988 • 261 citations

Correlation of Hormones with Lipid and Lipoprotein Levels During Normal Pregnancy and Postpartum*

1987 • 241 citations

Postmenopausal Estrogen Use and Heart Disease Risk Factors in the 1980s

1989 • 233 citations

Cholesterol, lipoproteins, and coronary heart disease in women.

1988 • 228 citations

Menopause: Physiology and Pharmacology

1986 • 214 citations

Subfractions of high-density lipoprotein cholesterol during estrogen replacement therapy: A comparison between progestogens and natural progesterone

1985 • 194 citations

Risk of Myocardial Infarction in Relation to Current and Discontinued Use of Oral Contraceptives

1981 • 187 citations

A randomized comparison of nonoral estradiol delivery in postmenopausal women

1988 • 168 citations

Relation of serum total cholesterol and high-density lipoprotein cholesterol percentage to the incidence of definite coronary events: Twenty-year follow-up of the donolo-Tel Aviv prospective coronary artery disease study

1987 • 157 citations

Oral contraceptives and cardiovascular disease: A critique of the epidemiologic studies

1985 • 151 citations

Marked Hyperlipidemia and Pancreatitis Associated with Oral Contraceptive Therapy

1973 • 148 citations

NATURAL ŒSTROGEN AS AN EFFECTIVE TREATMENT FOR TYPE-II HYPERLIPOPROTEINÆMIA IN POSTMENOPAUSAL WOMEN

1978 • 148 citations

Decrease in Plasma High-Density Lipoprotein Cholesterol Levels at Puberty in Boys With Delayed Adolescence

1987 • 143 citations

Changes in lipoprotein composition during the menstrual cycle

1979 • 135 citations

Coronary heart disease in women

1988 • 135 citations

Type III Hyperlipoproteinemia: Paradoxical Hypolipidemic Response to Estrogen

1977 • 135 citations

Mortality among oral contraceptive users

1988 • 117 citations

Ischaemic Heart Disease in Young Women

1974 • 115 citations

Menstrual and reproductive factors and the risk of myocardial infarction in women under fifty-five years of age

1987 • 112 citations

Estrogen-induced pancreatitis in patients with previously covert familial Type V hyperlipoproteinemia

1972 • 107 citations

Population-based lipoprotein lipid reference values for pregnant women compared to nonpregnant women classified by sex hormone usage

1982 • 105 citations

Norplant: Subdermal implant system for long-term contraception

1989 • 104 citations

METABOLIC ADJUSTMENTS IN NORMAL AND DIABETIC PREGNANCY

1981 • 95 citations

Efficacy of a continuous estrogen-progestin regimen in the menopausal patient.

1987 • 87 citations

Severe Endogenous Hypertriglyceridemia During Treatment with Estrogen and Oral Contraceptives¹

1968 • 70 citations

Treatment of Post-Menopausal Hypercholerolaemia with Estradiol

1979 • 69 citations

REPRODUCTIVE HISTORY IN WOMEN WITH CORONARY HEART DISEASE: A CASE-CONTROL STUDY

1984 • 69 citations

Continuous estrogen/progestin therapy in menopause

1987 • 68 citations

Progestins and oral contraceptive-induced lipoprotein changes: A prospective study

1986 • 68 citations

A prospective one-year study of estrogen and progestin in postmenopausal women: Effects on clinical symptoms and lipoprotein lipids

1989 • 66 citations

Myocardial Infarction in Women Under 50 Years of Age

1983 • 62 citations

Pharmacology of contraceptive steroids: A brief review

1989 • 60 citations

A randomized crossover comparison of two low-dose contraceptives: Effects on serum lipids and lipoproteins

1985 • 59 citations

Effect of Menstrual Cycle Phase on Plasma Lipids^*

1987 • 53 citations

Lipid and lipoprotein changes in women taking low-dose, triphasic oral contraceptives: A controlled, comparative, 12-month clinical trial

1989 • 51 citations

Lipid and lipoprotein changes associated with oral contraceptive use: a randomized clinical trial.

1988 • 50 citations

Effects of two low-dose oral contraceptives on serum lipids and lipoproteins: Differential changes in high-density lipoprotein subclasses

1983 • 47 citations

New progestogens in oral contraceptives

1987 • 46 citations

Myocardial infarction and angina pectoris in young women.

1987 • 43 citations

Chapter IX NUMBER OF PREGNANCIES, USE OF ORAL CONTRACEPTIVES AND MENOPAUSAL AGE IN WOMEN WITH ISCHAEMIC HEART DISEASE, COMPARED TO A POPULATION SAMPLE OF WOMEN

1973 • 42 citations

Clinical aspects of three new progestogens: Desogestrel, gestodene, and norgestimate

1989 • 40 citations

Reproductive hormone function: The perimenopausal period and beyond

1978 • 33 citations

Ovarian function, bleeding control and serum lipoproteins in women using contraceptive vaginal rings releasing five different progestins

1983 • 14 citations

The Effect of Ovariectomy on Lipoprotein Metabolism during a Period of One Year¹)

2009 • 4 citations

Effects of conjugated equine estrogen with and without three different progestogens on lipoproteins, high-density lipoprotein subfractions, and apolipoprotein A-I

1991 • 2 citations